Affordable Access

Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Authors
Keywords
  • Biology
  • Microbiology
  • Health Sciences
  • Medicine And Surgery
  • Health Sciences
  • Pharmacology
Disciplines
  • Design
  • Medicine

Abstract

Resistance to human immunodeficiency virus type 1 (HIV-1) represents a significant problem in the design of novel therapeutics and the management of treatment regimens in infected persons. Resistance profiles can be elucidated by defining modifications to the viral genome conferred upon exposure to novel nucleoside reverse transcriptase (RT) inhibitors (NRTI). In vitro testing of HIV-1LAI-infected primary human lymphocytes treated with β-d-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine (DFC; Dexelvucitabine; Reverset) produced a novel deletion of AGT at codon 68 (S68Δ) alone and in combination with K65R that differentially affects drug response. Dual-approach clone techniques utilizing TOPO cloning and pyrosequencing confirmed the novel S68Δ in the HIV-1 genome. The S68Δ HIV-1 RT was phenotyped against various antiviral agents in a heteropolymeric DNA polymerase assay and in human lymphocytes. Drug susceptibility results indicate that the S68Δ displayed a 10- to 30-fold increase in resistance to DFC, lamivudine, emtricitabine, tenofovir, abacavir, and amdoxovir and modest resistance to stavudine, β-d-2′,3′-oxa-5-fluorocytidine, or 9-(β-d-1,3-dioxolan-4-yl)guanine and remained susceptible to 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyinosine (ddI), 1-(β-d-dioxolane)thymine (DOT) and lopinavir. Modeling revealed a central role for S68 in affecting conformation of the β3-β4 finger region and provides a rational for the selective resistance. These data indicate that the novel S68Δ is a previously unrecognized deletion that may represent an important factor in NRTI multidrug resistance treatment strategies.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Selection and characterization of HIV-1 with a nov...

on Antimicrobial Agents and Chemo... May 2011

Virologic characterization of HIV type 1 with a co...

on Journal of acquired immune def... Aug 15, 2007

In vitro characterization of MK-1439, a novel HIV-...

on Antimicrobial Agents and Chemo... 2014

HIV1 reverse transcriptase: an out-of-the-ordinary...

on Bulletin de l Institut Pasteur Jan 01, 1998
More articles like this..